Cartmell Ventures is an early-stage fund focused on high impact, affordable health IT solutions that can be deployed globally. We typically take a board seat on the companies we invest in and provide advice through all growth stage activities.
What we’re looking for:
- Angel, pre-seed, & seed stage companies
- B2B and B2B2C solutions typically sold to payers and providers
- Founders / C-level executives with backgrounds in science & healthcare who are proven leaders with diverse teams
Emma Cartmell, MSc, FHIMSS
Ms. Cartmell is a proven health tech investor, following a 25-year career building, acquiring, selling and taking companies public.
She has served in multiple C-level positions for both public and private companies and has deep expertise in healthcare technology.
Under her leadership and guidance, healthcare companies have created and brought to market successful products and services that have led to successful exits.
Ms. Cartmell served as the COO of NantHealth, a $1B private equity fund where she built the team and led investments and acquisitions. Before that, Ms. Cartmell was the COO of Personalized Medicine at Abraxis BioScience where she prepared the company for sale and helped negotiate an 8x revenue sale to Celgene for $2.9B. Earlier in her career, she was VP of Healthcare Advanced Programs and Director of Business Development at SAIC where she held both P&L and revenue-generating responsibilities for a $500M healthcare business.
Ms. Cartmell serves on the boards of HIMSS North America and the Austin Healthcare Council. She is also a mentor to the United Healthcare Accelerator program. Ms. Cartmell was awarded the John. A Page Outstanding Service Award at HIMSS17 for her leadership in HIMSS and the Healthcare Industry.